Executive Director, Clinical Document Development

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The companys R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

The Opportunity:

We are seeking an Executive Director to lead the development of the clinical documents for the Development & Clinical Sciences (DCS) organization. This role will partner closely with Program and Development Teams and relevant functional leaders to design and implement their clinical study data disclosure and publications strategies and ensure alignment with the molecule strategy set by molecule team and the corporate strategy set by Investor Relations and the Senior Management Team. The candidate will be responsible for executing the strategic communications plan for DCS and ensuring consistency of messaging across molecules and disease indications for all stages of the clinical studies. They will also play a pivotal role in advising internal authors and working with functional and executive reviewers to incorporate feedback and institute best practices into the publication process. This individual will facilitate cross-functional alignment on the interpretation synthesis and description of clinical trial data and develop messaging to support publications and key internal and external stakeholder communications. The Executive Director will ensure budget headcount and the organization is effectively positioned to scale up and meet the substantially increasing demand for clinical trial documents and will collaborate closely with adjacent functions to identify and drive upstream improvements to process policy resource tools and document quality.

Responsibilities

• Lead the development of data disclosure and publication strategies for DCS in collaboration with Program and Development teams.

• Partner with Program and Development teams Medical Affairs Publication and Medical Communications Investor Relations and Senior Management to ensure DCS strategy aligns with and supports both program-level and enterprise strategies.

• Define and maintain key messages data narratives communication principles lexicons and message frameworks to ensure consistent terminology and positioning across all phases of oncology drug development and across functions.

• Facilitate and align the interpretation of clinical data in collaboration with Program Teams Clinical Development Biostatistics Safety Translational Medicine and other relevant functions to ensure scientifically sound and strategically aligned messaging.

• Translate complex clinical and scientific data into clear consistent narratives suitable for scientific strategic and investor communications.

• Provide strategic and technical oversight of content for manuscripts abstracts posters presentations and other external scientific communications.

• Partner closely with internal and external authors and cross-functional stakeholders to ensure alignment quality consistency and scientific rigor across all deliverables.

• Ensure consistency between published data external data disclosures (including investor communications) and internal materials; proactively identify and resolve discrepancies in messaging or data interpretation.

• Build lead and mentor a high-performing clinical document development team as applicable including setting strategic direction priorities and performance expectations.

Required Skills Experience and Education:

• BA/BS degree with a minimum of 15 years of experience in the biopharmaceutical industry.

• Extensive experience with at least 10 years in publishing in peer-reviewed journals across all phases of oncology drug development.

• Strong strategic thinking and analytical skills with the ability to make data-driven decisions and manage trade-offs in a fast-paced environment.

• Proven senior management experience with a track record of effective leadership collaboration and advancement of function-level capabilities.

• Demonstrated ability to work collaboratively and proactively across functions under challenging and shifting timelines including effective stakeholder communication when timelines change.

• Excellent written and verbal communication skills with the ability to interpret and present complex scientific and clinical trial data concisely accurately and with strong attention to detail.

• Demonstrated ability to oversee scale and optimize a function including efficient management of FTE and contract resources.

• Expertise in MS Word and related applications; familiarity with document management and review systems.

Preferred Skills:

• Pharm D or similar advanced degree within life science field with 10 or more years experience in medical writing publication or a related field in an agency or pharmaceutical/biotech industry.

  #LI-Hybrid #LI-GL1